Liu Jiaxiang~1, Niu Hongmei~2. Effects of Yiqi Yangyin Jiedu Fang on Serum Vascular Endothelial Growth Factor and Immunologic Function in the Patient of Lung Cancer[J]. Journal of Traditional Chinese Medicine2006, (3): 190-192.
Liu Jiaxiang~1, Niu Hongmei~2. Effects of Yiqi Yangyin Jiedu Fang on Serum Vascular Endothelial Growth Factor and Immunologic Function in the Patient of Lung Cancer[J]. Journal of Traditional Chinese Medicine2006, (3): 190-192.DOI: 10.13288/j.11-2166/r.2006.03.021.
Objective:To observe effects of Yiqi Yangyin Jiedu Fang on serum vascular endothelial growth factor(VEGF) and Immunologic function in the patient of non-small cell lung cancer(NSCLC).Methods:Fifty-one cases of NSCLC were randomly divided into a Chinese medicine group
a chemotherapy group and a chemotherapy plus Chinese medicine group.The therapeutic effect and changes of clinical symptoms
physical strength
immunologic indexes and serum VEGF before and after treatment were investigated in all groups.Results:Tumor stable rate in Chinese medicine group and chemotherapy plus Chinese medicine group after treatment was higher than that in chemotherapy group with no significant difference
but improvement of clinical symptoms and physical strength in Chinese medicine group and chemotherapy plus Chinese medicine group after treatment was significantly superior to that in chemotherapy group(both P<0.05).Interleukin-2(IL-2) level was significantly increased
and soluble IL-2 receptor(sIL-2R) were down-regulated(both P<0.01) in Chinese medicine plus chemotherapy group
and the therapeutic effect was significantly higher than that of the chemotherapy group(P<0.05); The total T-cell count was significantly increased and the sIL-2 level was down-regulated in Chinese medicine group(P<0.05 or P<0.01).Serum VEGF level significantly decreased after treatment in the Chinese medicine plus chemotherapy group(P<0.01).Conclusion:Yiqi Yangyin Jiedu Fang has functions of reducing and stabilizing the tumor focus
increasing immunologic function and quality of life
and decreasing VEGF level for the patient of NSCLC.